DNA Sequencing Detects Residual Leukemia
GenomeWeb Daily News reports that DNA sequencing is able to track cancerous blood cells in leukemia patients even when currently used methods cannot. The findings, published on May 16 in the journal Science Translational Medicine, suggest that high-throughput sequencing could improve the diagnosis and post-treatment monitoring of leukemia. The sequencing-based method is more sensitive than one of the two typical methods of detecting the malignant cells (flow cytometry) and cheaper and faster than the other (quantitative real-time PCR).
GenomeWeb notes that the Fred Hutchinson Cancer Research Center, one of the research institutions involved in the study, has applied for patents related to the technique.
Keep Reading
Most Popular
The big new idea for making self-driving cars that can go anywhere
The mainstream approach to driverless cars is slow and difficult. These startups think going all-in on AI will get there faster.
Inside Charm Industrial’s big bet on corn stalks for carbon removal
The startup used plant matter and bio-oil to sequester thousands of tons of carbon. The question now is how reliable, scalable, and economical this approach will prove.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
Stay connected
Illustration by Rose WongGet the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.